BIOCRYST PHARMACEUTICALS, INC.: cash_and_equivalents
| Value | {"amount": 96492000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2020-09-30) |
| Status | current |
| Entity | BIOCRYST PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:48:50.529413+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b6b14ed5-6d5b-4d55-8557-395a0d0f7047
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-20-007740Retrieved: 2026-08-19T08:48:50.529413+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000882796/cash-and-equivalents/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b6b14ed5-6d5b-4d55-8557-395a0d0f7047
History
- no predecessors — first report